Eugene Zhukovsky, Ph.D.Chief Scientific Officer, Research at Biomunex Pharmaceuticals
Dr. Zhukovsky has over two decades of experience in the biotherapeutics R&D. He applies optimized monospecific and novel bispecific antibody platforms to the development of immunotherapeutics for cancer, with a particular focus on leveraging the biology of immune checkpoint modulators. He is the CSO of Biomunex Pharmaceuticals, and also consults with other biotechnology companies.
Previously, he served as the CSO of Affimed. Prior to that he was a Senior Research Fellow in the Biotherapeutics Department at Boehringer Ingelheim Pharmaceuticals, Inc., and an Associate Director at Xencor, Inc. Dr. Zhukovsky performed a postdoctoral fellowship at Genentech, Inc. He received a PhD in biochemistry from Brandeis University.